FiercePharma12d
Verona touts 'exceptionally strong' launch of blockbuster hopeful COPD treatment Ohtuvayre
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
The Financial Express19h
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Unproven COPD treatments use doctored footage of Mehmet Oz, Snoop Dogg
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other drugs to manage the sometimes debilitating symptoms. However, ...
Rolling Out6d
Why COPD affects women differently
The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...
pulmonologyadvisor6d
Ensifentrine Is a Promising Ancillary COPD Treatment Option
Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...
News Medical on MSN5d
The impact of fall-risk medications on injuries in COPD patients
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Monthly Prescribing Reference13d
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...